Article Details

Y-mAbs Announces Publication of Phase 2 Interim Results in Nature Communications

Retrieved on: 2025-03-03 12:32:41

Tags for this article:

Click the tags to see associated articles and topics

Y-mAbs Announces Publication of Phase 2 Interim Results in Nature Communications. View article details on hiswai:

Excerpt

The article, titled “The anti-GD2 monoclonal antibody naxitamab plus GM-CSF for relapsed or refractory high-risk neuroblastoma: a phase 2 clinical ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo